Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study

CC Zouboulis; M M Okun; Errol Prens; R Gniadecki; PA Foley; C Lynde; J Weisman; YH Gu; DA Williams; GBE Jemec

doi:10.1016/j.jaad.2018.05.040

Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study

CC Zouboulis
, M M Okun
, Errol Prens
, R Gniadecki
, PA Foley
, C Lynde
, J Weisman
, YH Gu
, DA Williams
, GBE Jemec

Dermatology

Research output: Contribution to journal › Article › Academic › peer-review

178 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	60-+
Journal	Journal of the American Academy of Dermatology
Volume	80
Issue number	1
DOIs	https://doi.org/10.1016/j.jaad.2018.05.040
Publication status	Published - 2019

Research programs

EMC OR-01

Access to Document

10.1016/j.jaad.2018.05.040

http://hdl.handle.net/1765/109512

Cite this

Zouboulis, CC., Okun, M. M., Prens, E., Gniadecki, R., Foley, PA., Lynde, C., Weisman, J., Gu, YH., Williams, DA., & Jemec, GBE. (2019). Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study. Journal of the American Academy of Dermatology, 80(1), 60-+. https://doi.org/10.1016/j.jaad.2018.05.040

@article{baebd77263f04651ab85cf1128723263,

title = "Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study",

author = "CC Zouboulis and Okun, \{M M\} and Errol Prens and R Gniadecki and PA Foley and C Lynde and J Weisman and YH Gu and DA Williams and GBE Jemec",

year = "2019",

doi = "10.1016/j.jaad.2018.05.040",

language = "Undefined/Unknown",

volume = "80",

pages = "60--+",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Elsevier Inc.",

number = "1",

}

Zouboulis, CC, Okun, MM, Prens, E, Gniadecki, R, Foley, PA, Lynde, C, Weisman, J, Gu, YH, Williams, DA & Jemec, GBE 2019, 'Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study', Journal of the American Academy of Dermatology, vol. 80, no. 1, pp. 60-+. https://doi.org/10.1016/j.jaad.2018.05.040

Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study. / Zouboulis, CC; Okun, M M; Prens, Errol et al.
In: Journal of the American Academy of Dermatology, Vol. 80, No. 1, 2019, p. 60-+.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study

AU - Zouboulis, CC

AU - Okun, M M

AU - Prens, Errol

AU - Gniadecki, R

AU - Foley, PA

AU - Lynde, C

AU - Weisman, J

AU - Gu, YH

AU - Williams, DA

AU - Jemec, GBE

PY - 2019

Y1 - 2019

U2 - 10.1016/j.jaad.2018.05.040

DO - 10.1016/j.jaad.2018.05.040

M3 - Article

C2 - 29860040

SN - 0190-9622

VL - 80

SP - 60-+

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 1

ER -